Skip to main content
. Author manuscript; available in PMC: 2017 Sep 15.
Published in final edited form as: Ann Surg Oncol. 2013 Feb 23;20(8):2787–2795. doi: 10.1245/s10434-013-2886-9

Figure 1.

Figure 1

Study schema from intergroup trial (Alliance Trial #A021101). BLR PDAC, borderline resectable pancreatic adenocarcinoma; mFOLFIRINOX, modified FOLFIRINOX; EBRT, external beam radiation therapy; CAPE, capecitabine; GEM, gemcitabine.